Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences 2024

Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
Hacettepe University Faculty of Medicine, Department of Pediatrics, Clinic of Pediatric Endocrinology, Ankara, Turkey

Cardiovascular diseases (CVD) are the most important cause of morbidity and mortality in patients with type 1 diabetes (T1D). Children with T1D have a similar or higher prevalence of being overweight (OW) or obese (Ob) compared to healthy peers. The aim of this study was to determine the prevalence of CVD risk factors in children and adolescents with T1D and the impact of obesity and sex differences on these factors. Data of patients aged 10-21 years and who had been using intensive insulin therapy with a diagnosis of T1D for at least three years were evaluated. Patients were divided into normal weight (NW), OW and Ob groups based on body mass index percentiles. Risk factors for CVD (obesity, dyslipidemia, hypertension) were compared between groups, and impact of gender was also analyzed. Data of 365 patients (200 girls, 54.8%), were evaluated. Prevalence of OW/Ob was 25.9% and was significantly higher in girls (30.6% vs 20.1%, p<0.001). Rate of hypertension was highest in OW/Ob girls followed by OW/Ob boys, and similar in NW girls and boys (p=0.003). Mean low density lipoprotein cholesterol (LDL-c) and triglyceride (TG) levels were highest in OW/Ob girls, followed by OW/Ob boys, NW girls and NW boys, respectively (p<0.001 and p<0.001, respectively). Mean high density lipoprotein-cholesterol (HDL-c) levels were similar among groups. Rates of high LDL-c and TG were similar between OW/Ob girls and boys and higher than NW girls, followed by NW boys (p<0.001 and p<0.001, respectively). The rate of low HDL-c was similar in OW/Ob girls and boys, and higher than NW girls, followed by NW boys (p<0.001). Overall, girls were 1.9 times more likely than boys to have two or more risk factors for CVD. Factors associated with risk for CVD in multiple logistic regression analyses were being a girl, followed by higher daily insulin dose, higher hemoglobin A1c, and longer duration of diabetes (r=0.856; p<0.001). In spite of the increased prevalence for obesity in both sexes, the trend for CVD risk factors was greater in Ob girls, followed by Ob boys and NW girls. Girls with T1D are more likely to be OW/Ob and to have CVD risk than boys, highlighting the need for early intervention and additional studies to elucidate the causes.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082742 Heart Disease Risk Factors Aspects of personal behavior or lifestyle, environmental exposure, inherited conditions and characteristics, which are determined to be associated with HEART DISEASES. Cardiovascular Risk,Cardiovascular Risk Factors,Cardiovascular Risk Score,Residual Cardiovascular Risk,Risk Factors for Cardiovascular Disease,Risk Factors for Heart Disease,Cardiovascular Risk Factor,Cardiovascular Risk Scores,Cardiovascular Risk, Residual,Cardiovascular Risks,Factor, Cardiovascular Risk,Residual Cardiovascular Risks,Risk Factor, Cardiovascular,Risk Score, Cardiovascular,Risk, Cardiovascular,Risk, Residual Cardiovascular,Score, Cardiovascular Risk

Related Publications

Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
August 2012, European journal of pediatrics,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
March 2003, Diabetologia,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
January 2016, International journal of pediatric endocrinology,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
August 2012, Gender medicine,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
January 2017, Current diabetes reviews,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
July 2012, Diabetes research and clinical practice,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
June 1994, The Medical journal of Australia,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
January 2014, Women's health issues : official publication of the Jacobs Institute of Women's Health,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
April 2008, Diabetologia,
Doğuş Vurallı, and Lala Jalilova, and Ayfer Alikaşifoğlu, and Z Alev Özön, and E Nazlı Gönç, and Nurgün Kandemir
January 2010, The Diabetes educator,
Copied contents to your clipboard!